Journal of Antimicrobial Chemotherapy (1988) 22, 377-384
© 1988 The British Society for Antimicrobial Chemotherapy
research-article |
Elimination of nasal carriage of methicillin-resistant Staphylococcus aureus with mupirocin during a hospital outbreak
Department of Medical Microbiology, The London Hospital Medical College Turner Street, London E1 2AD, UK
Received 27 July 1987; accepted 25 March 1988
During a hospital outbreak of methicillin-resistant Staphylococcus aureus (MRSA), involving more than 200 patients, 40 patients and 32 hospital staff who were stable nasal carriers of MRSA received topical application of 2% mupirocin. formulated in a white soft paraffin and lanolin ointment, to their anterior nares for five days. Nasal carriage was eliminated in all patients and staff, usually within the first 48 h of treatment. Of the 40 patients, 36 remained clear of nasal MRSA for the duration of their follow-up (mean = 2 weeks) and four became re-colonized one to five weeks after their course. Immediately after the course, the number of patients with MRSA isolated from wounds and wrists fell from 16 to 7, and from 16 to 3, respectively. Of the 32 staff, all were negative one week after the course, and of the 22 still available for follow-up at eight weeks, all were consistently negative (mean period of follow-up = 7.8, range = 1–20 weeks). Four patients and five staff were re-colonized with MRSA between one to five, and two to twelve weeks, respectively, after treatment. Overall, in the post-treatment follow-up, 98.6% of the staff-weeks and 90.1% of the patient-weeks were free of nasal MRSA. MICs of mupirocin for both pre and post treatment isolates were all 0.03 or 0.06 mg/l. The elimination of nasal MRSA by mupirocin., and the introduction of isolation facilities, were associated with the control of the outbreak.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. E. Simor, T. L. Stuart, L. Louie, C. Watt, M. Ofner-Agostini, D. Gravel, M. Mulvey, M. Loeb, A. McGeer, E. Bryce, et al. Mupirocin-Resistant, Methicillin-Resistant Staphylococcus aureus Strains in Canadian Hospitals Antimicrob. Agents Chemother., November 1, 2007; 51(11): 3880 - 3886. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. G. Gemmell, D. I. Edwards, A. P. Fraise, F. K. Gould, G. L. Ridgway, R. E. Warren, and on behalf of the Joint Working Party of the Britis Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK J. Antimicrob. Chemother., April 1, 2006; 57(4): 589 - 608. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D S Thompson Methicillin-resistant Staphylococcus aureus in a general intensive care unit J R Soc Med, November 1, 2004; 97(11): 521 - 526. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Hardy, P. M. Hawkey, F. Gao, and B. A. Oppenheim Methicillin resistant Staphylococcus aureus in the critically ill Br. J. Anaesth., January 1, 2004; 92(1): 121 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Takahashi, K. Minami, M. Ogawa, H. Miyamoto, K. Ikemura, A. Shigematsu, and H. Taniguchi The Preventive Effects of Mupirocin Against Nasotracheal Intubation-Related Bacterial Carriage Anesth. Analg., July 1, 2003; 97(1): 222 - 225. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Francois, D. Pittet, M. Bento, B. Pepey, P. Vaudaux, D. Lew, and J. Schrenzel Rapid Detection of Methicillin-Resistant Staphylococcus aureus Directly from Sterile or Nonsterile Clinical Samples by a New Molecular Assay J. Clin. Microbiol., January 1, 2003; 41(1): 254 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R L R Hill The bioavailability of mupirocin in nasal secretions in vitro J. Clin. Pathol., March 1, 2002; 55(3): 233 - 235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Watanabe, H. Masaki, N. Asoh, K. Watanabe, K. Oishi, S. Kobayashi, A. Sato, R. Sugita, and T. Nagatake Low Concentrations of Mupirocin in the Pharynx following Intranasal Application May Contribute to Mupirocin Resistance in Methicillin-Resistant Staphylococcus aureus J. Clin. Microbiol., October 1, 2001; 39(10): 3775 - 3777. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Watanabe, H. Masaki, N. Asoh, K. Watanabe, K. Oishi, S. Kobayashi, A. Sato, and T. Nagatake Molecular Analysis of Methicillin-Resistant Staphylococcus aureus as a Causative Agent of Bronchopulmonary Infection: Relation to Colonization in the Upper Respiratory Tract J. Clin. Microbiol., October 1, 2000; 38(10): 3867 - 3869. [Abstract] [Full Text]
|
|
|
|
|
|
S. Harbarth, S. Dharan, N. Liassine, P. Herrault, R. Auckenthaler, and D. Pittet Randomized, Placebo-Controlled, Double-Blind Trial To Evaluate the Efficacy of Mupirocin for Eradicating Carriage of Methicillin-Resistant Staphylococcus aureus Antimicrob. Agents Chemother., June 1, 1999; 43(6): 1412 - 1416. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. P. Coll, B. F. Crabtree, P. J. O'Connor, and S. Klenzak Clinical Risk Factors for Methicillin-Resistant Staphylococcus aureus Bacteriuria in a Skilled-Care Nursing Home Arch Fam Med, April 1, 1994; 3(4): 357 - 360. [Abstract] [PDF]
|
|
|
|
 |
|
 R. W. Haley Methicillin-Resistant Staphylococcus aureus: Do We Just Have To Live with It? Ann Intern Med, January 15, 1991; 114(2): 162 - 164. [Abstract] [PDF]
|
|
|
|
 |
|
 L. R. Peterson, J. N. Quick, B. Jensen, S. Homann, S. Johnson, J. Tenquist, C. Shanholtzer, R. A. Petzel, L. Sinn, and D. N. Gerding Emergence of Ciprofloxacin Resistance in Nosocomial Methicillin-Resistant Staphylococcus aureus Isolates: Resistance During Ciprofloxacin Plus Rifampin Therapy for Methicillin-Resistant S aureus Colonization Arch Intern Med, October 1, 1990; 150(10): 2151 - 2155. [Abstract] [PDF]
|
|
|
|
|
|
J. W. Chow and V. L. Yu Staphylococcus aureus Nasal Carriage in Hemodialysis Patients: Its Role in Infection and Approaches to Prophylaxis Arch Intern Med, June 1, 1989; 149(6): 1258 - 1262. [Abstract] [PDF]
|
|